V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004236 | 300002974 | null | 71.6 | Curative (C) | 2015-04-21 | 2015-05-07 | Capecitabine + Oxaliplatin 21day | N | Y | 300022711 | ESPAC TRIAL |
| 300004237 | 300002975 | 1.82 | 53.7 | Curative (C) | 2015-02-12 | 2015-02-19 | Hydroxycarbamide | N | N | 300022731 | CARBOPLATIN |
| 300004238 | 300002975 | 1.78 | null | Palliative (P) | 2017-08-12 | 2017-08-24 | CAPECITABINE + OXALIPLATIN | N | N | 300022731 | CAPECITABINE + CISPLATIN |
| 300004239 | 300002975 | null | null | Curative (C) | 2017-05-23 | 2017-06-14 | Capecitabine + Oxaliplatin 21day | N | Y | 300022731 | DACARBAZINE |
| 300004240 | 300002975 | null | 98.15 | Adjuvant (A) | 2014-05-08 | 2014-05-15 | ABC-08 Trial | null | N | 300022731 | GEMCITABINE + NAB-PACLITAXEL |
| 300004242 | 300002977 | 1.54 | 63.5 | Palliative (P) | 2016-08-17 | 2016-08-17 | GemCarbo Days 1+8 | 02 | null | 300022759 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004244 | 300002979 | 1.59 | 70.8 | Palliative (P) | 2014-08-17 | 2014-08-31 | FEC + TRASTUZUMAB | Y | N | 300022762 | IMATINIB |
| 300004245 | 300002980 | 1.69 | 83.1 | Curative (C) | 2017-08-01 | 2017-08-14 | CARBOPLATIN | 02 | N | 300022775 | CARBOPLATIN + ETOPOSIDE |
| 300004246 | 300002981 | 1.74 | 78.8 | null | 2014-10-09 | 2014-10-30 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300022784 | CARBOPLATIN |
| 300004247 | 300002982 | 1.68 | 81.5 | null | 2014-03-06 | 2014-03-12 | Cisplatin + Fluorouracil + RT 5day | 01 | null | 300022796 | CARBOPLATIN + RT |
| 300004248 | 300002983 | 1.54 | 65.8 | Curative (C) | 2013-12-21 | 2013-12-27 | FEC + DOCETAXEL | N | Y | 300022800 | CAPECITABINE + GEMCITABINE |
| 300004250 | 300002985 | 0 | 80.2 | Adjuvant (A) | 2015-11-02 | 2015-11-15 | Docetaxel 100mg/m2 (21 day) | 02 | null | 300022812 | EC |
| 300004251 | 300002986 | 1.62 | 109 | Curative (C) | 2017-08-24 | 2017-10-10 | Folfirinox | 2 | Y | 300022815 | HYDROXYCARBAMIDE |
| 300004252 | 300002987 | 1.75 | 62.3 | Palliative (P) | 2017-10-30 | 2017-11-06 | Gemcitabine + Capecitabine | 2 | N | 300022816 | CARBOPLATIN + RT |
| 300004253 | 300002987 | 1.74 | 94 | Curative (C) | 2015-10-12 | 2015-10-12 | CISPLATIN + ETOPOSIDE | 2 | N | 300022816 | CAPECITABINE + CARBOPLATIN |
| 300004254 | 300002988 | 1.62 | 76 | Adjuvant (A) | 2017-07-25 | 2017-07-25 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | 300022826 | PEMBROLIZUMAB |
| 300004255 | 300002989 | null | 64 | Adjuvant (A) | 2014-04-09 | 2014-04-24 | Temozolomide 200mg/m2 | N | null | 300022831 | FLUOROURACIL + MITOMYCIN + RT |
| 300004256 | 300002989 | 1.61 | 80 | Palliative (P) | 2016-02-04 | 2016-02-04 | Cisplatin + Topotecan | 2 | N | 300022831 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004257 | 300002990 | 1.76 | 0 | Adjuvant (A) | 2013-03-15 | 2013-03-29 | ESPAC-4 TRIAL | N | N | 300022846 | CARBOPLATIN + RT |
| 300004258 | 300002991 | 1.7 | 74.8 | Palliative (P) | 2017-04-24 | 2017-05-08 | CompARE Trial | N | N | 300022849 | ECX |
| 300004259 | 300002992 | 1.61 | 78.6 | Neo-adjuvant (N) | 2017-08-24 | 2017-08-25 | FLUOROURACIL | 02 | N | 300022851 | IPILIMUMAB + NIVOLUMAB |
| 300004265 | 300002997 | 1.6 | 67 | Curative (C) | 2015-07-17 | 2015-08-06 | Paclitaxel (2 or 3 weekly) | N | Y | 300022887 | FLUOROURACIL + MITOMYCIN + RT |
| 300004266 | 300002997 | 1.55 | 64 | Adjuvant (A) | 2018-01-14 | 2018-01-24 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 300022887 | CISPLATIN + VINORELBINE |
| 300004267 | 300002997 | null | null | null | null | 2014-05-15 | Gemcitabine + Capecitabine | null | null | 300022887 | OXALIPLATIN + MDG |
| 300004268 | 300002998 | null | 64 | Adjuvant (A) | 2013-07-09 | 2013-07-29 | AML 19 TRIAL | null | N | 300022904 | ESPAC TRIAL |
| 300004269 | 300002999 | 1.67 | 94 | Curative (C) | 2014-09-02 | 2014-09-09 | Fluorouracil + Folinic Acid (Mayo) | 02 | N | 300022910 | GEMCARBO |
| 300004270 | 300003000 | 1.75 | 81.3 | Curative (C) | 2016-10-30 | 2016-11-03 | GEMCARBO | 02 | Y | 300022912 | CARBO + FLUOROURACIL |
| 300004276 | 300003002 | 1.65 | 57 | Adjuvant (A) | 2014-08-07 | 2014-08-26 | Carboplatin + Etoposide iv&po | N | N | 300022934 | CARBOPLATIN |
| 300004277 | 300003003 | 1.53 | 60 | Palliative (P) | 2017-08-30 | 2017-08-30 | Nilotinib | 1 | N | 300022935 | CAPECITABINE + GEMCITABINE |
| 300004278 | 300003004 | null | 104.8 | Curative (C) | null | 2016-09-04 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | N | N | 300022938 | CARBOPLATIN + RT |
| 300004279 | 300003005 | null | null | Adjuvant (A) | 2017-10-17 | 2017-10-27 | Folfirinox | N | N | 300022953 | CAPECITABINE + GEMCITABINE |
| 300004280 | 300003005 | 1.73 | 65 | Disease modification (D) | 2013-03-24 | 2013-05-20 | GEMCARBO | N | Y | 300022953 | CETUXIMAB + CISPLATIN + FU |
| 300004281 | 300003006 | 1.75 | null | Curative (C) | 2016-07-10 | 2016-07-23 | CAPECITABINE + GEMCITABINE | N | N | 300022956 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004282 | 300003006 | null | 74.45 | Neo-adjuvant (N) | 2014-07-17 | 2014-07-29 | CARBOPLATIN + GEMCITABINE | 01 | N | 300022956 | CARBO + FLUOROURACIL |
| 300004283 | 300003007 | 1.74 | 110.5 | Palliative (P) | 2017-02-16 | 2017-02-28 | Carboplatin + Docetaxel | N | N | 300022967 | CAPECITABINE + OXALIPLATIN |
| 300004284 | 300003008 | 1.61 | 102 | Curative (C) | 2013-06-14 | 2013-06-17 | Dacarbazine | 02 | Y | 300022968 | GEMCARBO |
| 300004285 | 300003009 | 1.57 | null | Curative (C) | 2013-08-01 | 2013-08-29 | GemCarbo Days 1+8 | 02 | Y | 300022971 | GEMCARBO |
| 300004286 | 300003010 | 1.63 | 93 | Not known (9) | 2017-12-14 | 2017-12-26 | ESPAC-4 TRIAL | 02 | N | 300022977 | BEVACIZUMAB |
| 300004287 | 300003011 | 1.85 | 88 | Palliative (P) | 2013-08-06 | 2013-08-28 | Carboplatin + Etoposide iv&po | 2 | N | 300022981 | CARBOPLATIN + RT |
| 300004288 | 300003011 | 1.62 | 63.4 | Curative (C) | 2016-02-26 | 2016-03-19 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL + Pertuzumab + Trastuzumab | 2 | Y | 300022981 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004289 | 300003012 | 1.73 | 77 | Curative (C) | 2014-04-05 | 2014-04-25 | Gemcitabine + Capecitabine | 02 | N | 300022992 | CAPECITABINE + GEMCITABINE |
| 300004290 | 300003013 | 1.8 | 58.6 | Palliative (P) | 2017-08-14 | 2017-08-15 | Carboplatin AUC 2 - 5 | 02 | null | 300022994 | CISPLATIN + FLUOROURACIL + RT |
| 300004291 | 300003014 | 1.25 | 101.3 | Neo-adjuvant (N) | 2017-06-30 | 2017-07-13 | Carboplatin AUC 2 - 5 | 01 | N | 300022997 | CISPLATIN + ETOPOSIDE |
| 300004292 | 300003015 | 1.68 | null | Curative (C) | 2016-01-06 | 2016-01-21 | Temozolomide 150mg/m2 | N | N | 300023002 | CARBO + FLUOROURACIL |
| 300004293 | 300003016 | 1.76 | 113 | Palliative (P) | 2017-05-22 | 2017-06-04 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 300023009 | ESPAC TRIAL |
| 300004294 | 300003016 | 1.8 | 66.8 | null | 2016-12-07 | 2016-12-14 | Folfirinox | N | N | 300023009 | GEMCARBO |
| 300004295 | 300003017 | 1.77 | 99.1 | Curative (C) | 2014-08-27 | 2014-09-03 | Folfirinox | 02 | Y | 300023013 | CARBOPLATIN + RT |
| 300004296 | 300003018 | 1.78 | 88 | Palliative (P) | 2017-09-07 | 2017-09-07 | Temozolomide + RT | N | N | 300023014 | DABRAFENIB + TRAMETINIB |
| 300004297 | 300003019 | 1.6 | 37.8 | Adjuvant (A) | 2014-10-21 | 2014-11-10 | DE-ESCALATE TRIAL | 02 | N | 300023021 | BEVACIZUMAB |
| 300004298 | 300003019 | 1.55 | 46.8 | Palliative (P) | 2017-10-26 | 2017-11-01 | FLUOROURACIL + MITOMYCIN | N | N | 300023021 | CARBO + FLUOROURACIL |